Difference in mobilization of progenitor cells after myocardial infarction in smoking versus non-smoking patients: insights from the BONAMI trial. - Archive ouverte HAL Access content directly
Journal Articles Stem Cell Research and Therapy Year : 2013

Difference in mobilization of progenitor cells after myocardial infarction in smoking versus non-smoking patients: insights from the BONAMI trial.

(1, 2) , (3, 4) , (1) , (3) , (5) , (6) , (7) , (8) , (1, 2) , (9) , (7) , (8) , (4, 3) , (10) , (2, 1)
1
2
3
4
5
6
7
8
9
10
Jérôme Roncalli

Abstract

INTRODUCTION: Although autologous bone marrow cell (BMC) therapy has emerged as a promising treatment for acute myocardial infarction (AMI), trials reported mixed results. In the BONAMI trial, active smoking reduced cardiac function recovery after reperfused AMI. Therefore, we hypothesized that variability in the functionality of BMCs retrieved from patients with cardiovascular risk factors may partly explain these mixed results. We investigated the characteristics of progenitor cells in active smokers and non-smokers with AMI and their potential impact on BMC therapy efficacy. METHODS: Bone marrow and blood samples from 54 smoking and 47 non-smoking patients enrolled in the BONAMI cell therapy trial were analyzed. RESULTS: The white BMC and CD45dimCD34+ cell numbers were higher in active smokers (P = 0.001, P = 0.03, respectively). In marked contrast, either bone marrow or blood endothelial progenitor CD45dimCD34 + KDR + cells (EPCs) were decreased in active smokers (P = 0.005, P = 0.04, respectively). Importantly, a multivariate analysis including cardiovascular risk factors confirmed the association between active smoking and lower EPC number in bone marrow (P = 0.04) and blood (P = 0.04). Furthermore, baseline circulating EPC count predicted infarct size decrease at three months post-AMI in non-smokers (P = 0.01) but not in active smokers. Interestingly, baseline circulating EPCs were no longer predictive of cardiac function improvement in the BMC therapy group. CONCLUSIONS: These data suggest that circulating EPCs play an important role in cardiac repair post-AMI only in non-smokers and that active smoking-associated EPC alterations may participate in the impairment of cardiac function recovery observed in smokers after AMI, an effect that was overridden by BMC therapy.
Fichier principal
Vignette du fichier
Lamirault_et_al._Stem_Cell_Research_Therapy_2013.pdf (562.15 Ko) Télécharger le fichier
Origin : Publisher files allowed on an open archive
Loading...

Dates and versions

inserm-00932365 , version 1 (16-01-2014)

Identifiers

Cite

Guillaume Lamirault, Sophie Susen, Virginie Forest, Caroline Hemont, Angelo Parini, et al.. Difference in mobilization of progenitor cells after myocardial infarction in smoking versus non-smoking patients: insights from the BONAMI trial.. Stem Cell Research and Therapy, 2013, 4 (6), pp.152. ⟨10.1186/scrt382⟩. ⟨inserm-00932365⟩
763 View
258 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More